Mainstream

Secarna pharmaceuticals and vect horus announce research collaboration to advance systemic delivery of rna targeted therapeutics for cns disorders

Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders

Secarna Pharmaceuticals and Vect-Horus Announce Research Collaboration to Advance Systemic Delivery of RNA-Targeted Therapeutics for CNS Disorders

The partnership combines Secarna’s OligoCreator ® technology with Vect-Horus’ VECTrans ® platform to enable systemic delivery of…Read More

You might also be interested in reading BNB price low-volume rebound signals increased risk of a fall toward $800.

July 10, 2025
In Mainstream